This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Oxford vaccine team nominated for Parliamentary Award
25/11/2020
The Oxford Vaccine Group and Jenner Institute are up for the Excellence in Healthcare Award
The University of Oxford team who have developed a COVID-19 vaccine in record time have been shortlisted for the Excellence in Healthcare Award at the NHS Parliamentary Awards.
The team from the Oxford Vaccine Group and Jenner Institute were nominated by Layla Moran, MP for Oxford West and Abingdon, and won the regional Excellence in Healthcare award.
The news coincided with announcement of interim data from phase III of the vaccine trial, which showed that the Oxford candidate vaccine was effective at preventing COVID-19 and offered a high level of protection. One dosing regimen indicated that the vaccine is 90 percent effective.
Layla Moran said: “I’m absolutely delighted. There were nearly 700 nominations by MPs this year, so to be shortlisted is a huge achievement – the vaccine team really deserve it!
“The Oxford Vaccine Group and the Jenner Institute have been working so incredibly hard since the beginning of the pandemic to produce a vaccine that will be life changing for so many people around the world. They’re the jewel in our community’s crown.
The NHS Parliamentary Awards are an annual opportunity to recognise and appreciate the very best about our local healthcare service.
Professor Andrew Pollard, Director of Oxford Vaccine Group, said: “We are delighted and honoured that our vaccine teams have been shortlisted, and a real boost to us all after tireless efforts of the year to test the Oxford vaccine across the UK, Brazil and South Africa.
“We have been fully focused on developing a vaccine for the NHS, that could also reach all corners of the world and it is wonderful to be part of the NHS awards list.”
Dr Bruno Holthof, Chief Executive of Oxford University Hospitals, said: “We are very proud of the close and dynamic relationship between the University and our Trust, and of the world-leading research that takes place here. The Oxford vaccine team, who have worked tirelessly to find a vaccine since the start of the pandemic, are worthy recipients of this recognition. It is fitting that they have learned of this recognition as they publish such positive and hopeful findings about the trial.”
The Oxford vaccine team will now compete with other regional winners from across the country to be judged by a national panel made up of senior leaders representing staff and patients, for the chance to win the prestigious national award which will be presented at a special ceremony in the House of Commons on 7 July 2021.
Published: by Banbury FM Newsteam